full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
full issue - Association of Biotechnology and Pharmacy
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Current Trends in <strong>Biotechnology</strong> <strong>and</strong> <strong>Pharmacy</strong><br />
Vol. 5 (3) 1251-1272 July 2011, ISSN 0973-8916 (Print), 2230-7303 (Online)<br />
Bosentan, a dual endothelin receptor<br />
antagonist. Clin Pharmacokinet, 43: 1089-<br />
1115.<br />
56. Iglarz, M., Binkert, C., Morrison, K.,<br />
Fischli, W., Gatfield, J., Treiber, A., Weller,<br />
T., Bolli, M.H., Boss, C., Buchmann, S.,<br />
Capeleto, B., Hess, P., Qiu, C. <strong>and</strong> Clozel,<br />
M. (2008). Pharmacology <strong>of</strong> macitentan,<br />
an orally active t<strong>issue</strong>-targeting dual<br />
endothelin receptor antagonist. J Pharmacol<br />
Exp Ther., 327: 736-745.<br />
57. Raja, S.G. (2010). Macitentan, a t<strong>issue</strong>targeting<br />
endothelin receptor antagonist for<br />
the potential oral treatment <strong>of</strong> pulmonary<br />
arterial hypertension <strong>and</strong> idiopathic<br />
pulmonary fibrosis. Curr Opin Investig<br />
Drugs, 11: 1066-1073.<br />
58. Miller, R.C., Pelton, J.T.<strong>and</strong> Huggins, J.P.<br />
(1993). Endothelins – from receptors to<br />
medicine. TiPS, 14: 54-60.<br />
59. Doherty, A.M. (1992). Endothelin: a new<br />
challenge. Journal <strong>of</strong> Medicinal Chemistry,<br />
35: 1493-1508.<br />
60. Reily, M.D.<strong>and</strong> Dunbar, J.B. (1991). The<br />
conformation <strong>of</strong> endothelin-1 in aqueous<br />
solution. NMR-derived constrains<br />
combined with distance geometry <strong>and</strong><br />
molecular mechanisms calculations.<br />
Biochem Biophys Res Commun., 178: 570-<br />
577.<br />
61. Takasaki, C., Aimoto, S., Tkayanagi, R.,<br />
Ohashi, M. <strong>and</strong> Nawata, H. (1990).<br />
Structure-receptor binding relationships <strong>of</strong><br />
sarafotoxin <strong>and</strong> endothelin in porcine<br />
cardiovascular t<strong>issue</strong>s. Biochem Int., 21:<br />
1059-1064.<br />
62. Fukami, T., Nagase, T., Fujita, K., Hayama,<br />
T., Niiyama, K., Mase, T., Nakajima, S.,<br />
Fukuroda, T., Saeki, T., Nishikibe, M.,<br />
Ihara, M., Yano, M. <strong>and</strong> Ishikawa, K.<br />
Does nature has the cure for hypertension<br />
1270<br />
(1995). Structure-activity relationships <strong>of</strong><br />
cyclic pentapeptide endothelin A receptor<br />
antagonists. J Med Chem., 38: 4309-4324.<br />
63. Ishikawa, K., Fukami, T., Nagase, T., Mase,<br />
T., Hayama, T., Niiyama, K., Fujita, K.,<br />
Urakawa, Y., Kumagai, U., Fukuroda, T.,<br />
Ihara, M. <strong>and</strong> Yano, M. (1992). Endothelin<br />
antagonistic peptide derivatives with high<br />
selectivity for ET A<br />
receptors. In<br />
Proceedings <strong>of</strong> the 22 nd European Peptide<br />
Symposium; ESCOM Science Publishers<br />
B.V.: Leiden, The Nederl<strong>and</strong>s, 1992, pp<br />
685-686.<br />
64. Winn, M., von Geldern, T.W., Opgenorth,<br />
T.J., Jae, H., Tasker, A.S., Boyd, S.A.,<br />
Kester, J.A., Mantei, R.A., Bal, R.,<br />
Sorensen, B.K., Wu-Wong, J.R., Chiou,<br />
W.J., Dixon, D.B., Novosad, E.I.,<br />
Hern<strong>and</strong>ez, L. <strong>and</strong> Marsh, K.C. (1996). 2,4-<br />
Diarylpyrrolidine-3-carboxylic acidspotent<br />
ET A<br />
selective endothelin receptor<br />
antagonists. 1. Discovery <strong>of</strong> A-127722. J<br />
Med Chem., 39: 1039-1048.<br />
65. Sakurawi, K., Yasuda, F., Tozyo, T.,<br />
Nakamura, M., Sato, T., Kikuchi, J., Terui,<br />
Y., Ikenishi, Y., Iwata, T., Takahashi, K.,<br />
Konoike, T., Mihara, S. <strong>and</strong> Fujimoto, M.<br />
(1996). Endothelin receptor antagonist<br />
triterpenoid, myriceric acid A, isolated from<br />
Myrica cerifera, <strong>and</strong> structure activity<br />
relationships <strong>of</strong> its derivatives. Chem<br />
Pharm Bull (Tokyo), 44: 343-351.<br />
66. Timmermans, P.B. (1999). Angiotensin II<br />
receptor antagonists: an emerging new class<br />
<strong>of</strong> cardiovascular therapeutics. Hypertens<br />
Res., 22: 147-153.<br />
67. Kojiri, K., Ihara, M., Nakajima, S.,<br />
Kawamura, K., Funaishi, K., Yano, M. <strong>and</strong><br />
Suda, H. (1991). Endothelin-binding<br />
inhibitors, BE-18257A <strong>and</strong> BE-18257B. I.